Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment

• Published in: Neuropsychiatric disease and treatment 2019-04, Vol.15, p.819-829
• Main Authors: Jarzemski, Piotr, Brzoszczyk, Bartosz, Popiołek, Alicja, Stachowicz-Karpińska, Agnieszka, Gołota, Szymon, Bieliński, Maciej, Borkowska, Alina
• Format: Article
• Language: English
• Subjects: Adjuvant therapy; Adjuvants; Androgens; Antigens; Anxiety; Cancer; Cancer surgery; Cancer therapies; Care and treatment; cognition; Cognitive ability; Cognitive disorders; depression; Depression (Mood disorder); Development and progression; Disease susceptibility; Family medical history; Hospitals; Incontinence; Industrialized countries; Kopernik, Mikolaj (Nicolaus Copernicus) (1473-1543); Laparoscopy; Medical examination; Memory; Mental depression; Mental disorders; Mental health services; Older people; Original Research; Patients; Prostate cancer; Prostate-specific antigen; Prostatectomy; Psychological aspects; Quality of life; Questionnaires; Radiation therapy; Radiotherapy; Sexual disorders; sexual dysfunction; Short term memory; Surgery; Systematic review; Testosterone; Time; Tumors; Urinary incontinence; Urological surgery; Well being
• ISSN: 1176-6328; 1178-2021; 1178-2021
• DOI: 10.2147/NDT.S200501

Prostate cancer (PC) is one of the most common malignant tumors in developed countries. Both PC and treatment for PC have an adverse impact on physical and mental well-being, and are associated with decreased quality of life. The aim of the present study was to examine the relationship between neuropsychological symptoms and clinical course in PC patients undergoing radical prostatectomy with or without adjunct therapy. The cohort comprised 100 patients aged 50-77 years who underwent radical, laparoscopic prostatectomy for PC. Twenty-three patients with a more advanced clinical stage also received adjuvant therapy (radiotherapy and hormonotherapy). Clinical evaluation included self-report assessment, physical examination, and biochemical tests (testosterone and prostate-specific antigen). In addition, the presence and intensity of sexual dysfunction, urinary dysfunction, anxiety-depressive symptoms, and cognitive dysfunction were assessed. The group of patients undergoing complex therapy was characterized by a significantly worse result of deferred memory ( =0.04). A significant correlation was found between post-surgery erectile function and scores for the visual working memory test (correct answers; VWMT-C; =0.006) and Hospital Anxiety and Depression Scale depression ( =0.045) and anxiety scores ( =0.02). A trend toward significance was also observed for simple reaction time (correct answers; =0.09). A significant correlation was found between results for the delayed verbal memory test and all physical symptoms (International Consultation on Incontinence Questionnaire-total, =0.02; International Index of Erectile Function-5, =0.006). Similarly, a significant correlation was found between the VWMT-C and score for sexual dysfunction ( =0.003). Patients undergoing both surgical and adjunct therapy for PC are at risk for psychological burden and cognitive disorders. In the present cohort, physical complications of therapy were associated with depression, anxiety, and delayed memory dysfunction. Furthermore, this study has proven that fewer complications after surgery are associated with better psychological and cognitive functioning. Appropriate neuropsychological and psychiatric care can improve compliance and quality of life among patients after prostatectomy.